Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters

International Journal of Pharmaceutics

Volumn 149, Issue 2, 1997, Pages 255-265

  Almeida, António J ^a   Runge, Stephan ^b   Müller, Rainer H ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Lysozyme; Protein antigens; Solid lipid nanoparticles; Vaccines

Indexed keywords

DRUG CARRIER; EXCIPIENT; LYSOZYME; NANOPARTICLE; VACCINE;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SOLUBILIZATION; SURFACE PROPERTY;

EID: 0030944482     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)04885-0     Document Type: Article

References (28)

1. Allison, A.C. and Gregoriadis, G., Liposomes as immunological adjuvants. Nature, 252 (1974) 252.
2. Almeida, A.J., Particulate Carriers as Immunological Adjuvants, Ph.D. Thesis, The University of Aston in Birmingham, UK, 1993.
3. Almeida, A.J., Alpar, H.O., Williamson, D. and Brown, M.R.W., Poly(lactic acid) microspheres as immunological adjuvants for orally delivered cholera toxin B subunit. Biochem. Soc. Trans., 20 (1992) 316S.
4. Alonso, M.J., Gupta, R.K., Min, C., Siber, G.R. and Langer, R., Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine, 12 (1994) 299-306.
5. Amselem, S., Domb, A.J. and Alving, C.R., Lipospheres as a vaccine carrier system: effects of size, charge, and phospholipid composition. Vaccine Res., 1 (1992) 383-395.
6. Browning, M., Reid, G., Osborne, R. and Jarrett, O., Incorporation of soluble antigens into ISCOMs: HW gp120 ISCOMs induce virus neutralising antibodies. Vaccine, 10 (1992) 585-590.
7. Chen, T., Formulation concerns of protein drugs. Drug Dev. Ind. Pharm., 18 (1992) 1311-1354.
8. Dobson, C.M., Evans, P.A. and Radford, S.E., Understanding how proteins fold: the lysozyme story so far. TIBS, 19 (1994) 31-37.
9. Edman, P. and Sjöholm, I., Acrylic microspheres in vivo. V. Immunological properties of immobilized asparaginase in microparticles. J. Pharm. Sci., 71 (1982) 576-580.
10. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., Tice, T.R. and Gilley, R.M., Biodegradable and biocompatible poly(D,L-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun., 59 (1991) 2978-2986.
11. Jollès, P., Relationship between chemical structure and biological activity of hen egg white lysozyme and lysozymes of different species. Proc. R. Soc. Ser. B, 167 (1967) 350-364.
12. Lenaerts, V., Couvreur, P., Christiaens-Leyh, D., Joiris, E., Roland, M., Rollman, E. and Speiser, P., Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials, 5 (1984) 65-68.
13. Lugtenberg, B., Meijers, J., Peters, R., Van der Hoek, P. and Van Alphen, L., Electrophoretic resolution of the 'major outer membrane protein' of Escherichia coli K12 into four bands. FEBS Lett., 58 (1975) 254-258.
14. Maaßen, S., Schwarz, C., Mehnert, W., Lucks, J.S., Yunis-Specht, F., Müller, B.W. and Müller, R.H., Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles. Proc. Int. Symp. Control. Release Bioact. Mater., 20 (1993) 490-491.
15. Müller, R.H., Mehnert, W., Lucks, J.S., Schwarz, C., zur Mühlen, A., Weyhers, H., Freitas, C. and Rühl, D., Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm., 41 (1995) 62-69.
16. Norde, W., Physicochemical aspects of the behaviour of biological components at solid/liquid interfaces. In Davis, S.S., Illum, L., McVie, J.G. and Tomlinson, E. (Eds), Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, Elsevier, Amsterdam, 1984, pp. 39-59.
17. Norde, W. and Favier, J.P., Structure of adsorbed and desorbed proteins. Colloids Surfaces, 64 (1992) 87-93.
18. O'Hagan, D.T., Palm, KJ. and Davis, S.S., Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunisation. Vaccine, 7 (1989) 213-216.
19. Portenhauser, R., Standards and reference materials. In Bergmeyer, H.V. (Ed), Methods in Enzymatic Analysis, Vol. 11, Verlag-Chemie, Basel, 1983, pp. 393-440.
20. Sieckmann, B. and Westesen, K., Submicron-sized parenteral carrier systems based on lipids. Pharm. Pharmacol. Lett., 1 (1992) 123-126.
21. Sieckmann, B. and Westesen, K., Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surfaces B: Biointerfaces, 3 (1994) 159-175.
22. Singh, M., Singh, A. and Talwar, G.P., Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microparticles. Pharm. Res., 8 (1991) 958-961.
23. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.T., Goeke, N.M., Olson B.J. and Klenk, D.C., Measurement of proteins using bicinchoninic acid. Anal Biochem., 150 (1985) 76-85.
24. Stieneker, F., Kreuter, J. and Löwer, J., High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines. AIDS, 5 (1991) 431-435.
25. Sugar, D., The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim. Biophys. Acta, 8 (1952) 302-309.
26. Trenktrog, T. and Müller, B.W., Production and characterization of a peptide containing w/o emulsion. Int. J. Pharm., 123 (1995) 199-208.
27. Weyhers, H., Feste Lipid Nanopartikel (SLN) für die Gewebsspezifische Arneistoffapplikation, Ph.D. Thesis, Freie Universitat Berlin, Germany, 1995.
28. Wüthrich, P., Ng, S.Y., Fritzinger, B.K., Roskos, K.V. and Heller, J., Pulsatile release of lysozyme from ointment-like poly(ortho esters). J. Control. Release, 21 (1992) 191-200.